Patents by Inventor Rosalyn B. Irby

Rosalyn B. Irby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutated Src oncogene composition and methods
    Patent number: 7803909
    Abstract: The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant polypeptide are also provided. The invention further relates to methods for utilizing such oligonucleotides, polypeptides, agonists and antagonists for applications, which relate to research, diagnostics, and clinical arts. More specifically, this invention provides methods of diagnosing, treating, immunizing, and creating transgenic animals based on use of such mutant Src.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: September 28, 2010
    Assignee: University of South Florida
    Inventors: Timothy J. Yeatman, Rosalyn B. Irby
  • Mutated Src oncogene composition and methods
    Publication number: 20080163387
    Abstract: The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant polypeptide are also provided. The invention further relates to methods for utilizing such oligonucleotides, polypeptides, agonists and antagonists for applications, which relate to research, diagnostics, and clinical arts. More specifically, this invention provides methods of diagnosing, treating, immunizing, and creating transgenic animals based on use of such mutant Src.
    Type: Application
    Filed: June 7, 2007
    Publication date: July 3, 2008
    Inventors: Timothy J. Yeatman, Rosalyn B. Irby
  • Mutated Src oncogene composition and methods
    Patent number: 7276581
    Abstract: The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant polypeptide are also provided. The invention further relates to methods for utilizing such oligonucleotides, polypeptides, agonists and antagonists for applications, which relate to research, diagnostics, and clinical arts. More specifically, this invention provides methods of diagnosing, treating, immunizing, and creating transgenic animals based on use of such mutant Src.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: October 2, 2007
    Assignee: University of South Florida
    Inventors: Timothy J. Yeatman, Rosalyn B. Irby
  • Mutated Src oncogene composition and methods
    Publication number: 20040261142
    Abstract: The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant polypeptide are also provided. The invention further relates to methods for utilizing such oligonucleotides, polypeptides, agonists and antagonists for applications, which relate to research, diagnostics, and clinical arts. More specifically, this invention provides methods of diagnosing, treating, immunizing, and creating transgenic animals based on use of such mutant Src.
    Type: Application
    Filed: July 9, 2004
    Publication date: December 23, 2004
    Inventors: Timothy J. Yeatman, Rosalyn B. Irby
  • Mutated Src oncogene composition and methods
    Patent number: 6764833
    Abstract: The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant polypeptide are also provided. The invention further relates to methods for utilizing such oligonucleotides, polypeptides, agonists and antagonists for applications, which relate to research, diagnostics, and clinical arts. More specifically, this invention provides methods of diagnosing, treating, immunizing, and creating transgenic animals based on use of such mutant Src.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: July 20, 2004
    Assignee: University of South Florida
    Inventors: Timothy J. Yeatman, Rosalyn B. Irby